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Identity 
Other names: Chromophilic renal cell carcinoma 
Classification 
Note: Renal cell carcinomas form a heterogeneous 
group of tumours which can be divided into several 
subgroups according to their cytology, architecture, and 
the part of the nephron from which tumour cells are 
derived: five basic cell types are recognized: clear-cell, 
chromophilic-cell (also called papillary renal cell 
carcinomas (PRCC), herein described), chromophobic-
cell, oncocytic-cell, and collector duct cell types. 
A certain correlation exists between cell type and 
architecture of the tumour: the clear-cell type tends to 
show compact growth, while the chromophilic-cell type 
is more readily associated with tubulo-papillary 
architecture. 
Clinics and pathology 
Etiology 
A hereditary form, called Hereditary papillary renal cell 
carcinoma, of autosomal dominant transmission, has 
been recently recognized; it predisposes to develop 
multiple, bilateral renal tumours. 
Epidemiology 
Papillary renal cell carcinomas (PRCC) represent about 
10% of all renal cell tumours; there is a clear excess of 
male patients (male to female ratio: 5 to 1). 
Pathology 
Papillary renal tumours are composed of at least 50% 
of papillary structures, formed by connective tissue 
stalks covered by small or medium size cuboid cells 
with eosinophilic or basophilic granular cytoplasm. 
Renal cortical adenomas are frequently associated with 
PRCC in the same kidney, suggesting the possibility of 
transformation from adenoma to carcinoma. 
Cytogenetics 
Note: Except a very rare subtype characterized by a 
translocation t(X;1)(p11;q21) or other abnormalities 
involving Xp11, PRCC do not show a recurrent 
structural chromosome rearrangement, but display non 
random numerical abnormalities; this contrasts with 
clear-cell renal cell carcinomas which are associated 
with various deletions of 3p. 
PRCC are characterized by loss of Y chromosome in 
men, trisomy or tetrasomy 7 and 17, trisomies 16, 20, 
and 12, by order of frequency; these chromosome 
imbalances have been confirmed by genomic 
comparative hybridization. 
Multifocal PRCC show the same numerical anomalies, 
with trisomies sometimes in various combinations in 
tumours within the same kidney or in both kidneys. 
The confrontation of karyotypic abnormalities with 
histopathological data suggest that specific 
chromosome imbalances may make it possible to 
distinguish benign papillary adenoma from malignant 
PRCC; the small papillary tumours without any 
morphological or clinical sign of malignancy are 
characterized by a combination of loss of Y, and excess 
of chromosomes 7 and 17, only, whereas tumours with 
aggressive growth and metastatic dissemination show 
more complex karyotypic changes, in addition to 
polysomy 7 and 17; it is suggested that tumours with 
tri- or tetrasomy 7 and 17 correspond to papillary 
adenomas, and that tumours with more complex 
karyotypic changes are papillary carcinomas, 
irrespective of their size. 
Genes involved and Proteins 
Note: In hereditary PRCC, linkages studies have shown 
that the gene of the disease could be located at 7q31.1-
34, between markers D7S496 and D7S1837, an interval 
containing the MET proto-oncogene; missense 
mutations in the tyrosine kinase domain of the MET 
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gene have been identified in the germline of affected 
members of PRCC families, and in a subset of sporadic 
PRCC. 
References 
Thoenes W, Störkel S, Rumpelt HJ. Histopathology and 
classification of renal cell tumors (adenomas, oncocytomas 
and carcinomas). The basic cytological and histopathological 
elements, and their use for diagnosis. Pathol Res Pract. 1986 
May;181(2):125-43. 
Kovacs G. Papillary renal cell carcinoma. A morphologic and 
cytogenetic study of 11 cases. Am J Pathol. 1989 
Jan;134(1):27-34. 
Kovacs G, Fuzesi L, Emanuel A, Kung HF. Cytogenetics of 
papillary renal cell tumors. Genes Chromosomes Cancer. 1991 
Jul;3(4):249-55. 
Hughson MD, Johnson LD, Silva FG, Kovacs G. Nonpapillary 
and papillary renal cell carcinoma: a cytogenetic and 
phenotypic study. Mod Pathol. 1993 Jul;6(4):449-56. 
Kovacz G. Molecular cytogenetics of renal cell tumors. Adv 
Cancer Res. 1993;62:89-124. 
Bentz M, Bergerheim US, Li C, Joos S, Werner CA, Baudis M, 
Gnarra J, Merino MJ, Zbar B, Linehan WM, Lichter P. 
Chromosome imbalances in papillary renal cell carcinoma and 
first cytogenetical data of familial cases analysed by 
comparative genomic hybridization. Cytogenet Cell Genet. 
1996;75(1):17-21. 
Dal cin P, van Poppel H, van Damme B, Baert L, Van den 
Berghe H. Cytogenetic investigation of synchronous bilateral 
renal tumors. Cancer Genet Cytogenet. 1996 Jul 1;89(1):57-
60. 
Schmidt L, Duh FM, Chen F, et al. Germline and somatic 
mutations in the tyrosine kinase domain of the MET proto-
oncogene in papillary renal carcinomas. Nat Genet. 1997 
May;16(1):68-73. 
Dal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van 
den Berghe H. Translocation (X;1) reveals metastasis 31 years 
after renal cell carcinoma. Cancer Genet Cytogenet. 1998 
Feb;101(1):58-61. 
This article should be referenced as such: 
Couturier J. Kidney: Papillary renal cell carcinoma. Atlas Genet 
Cytogenet Oncol Haematol.1998;2(4):146-147.  
 
 
 
